Cargando…

Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study

BACKGROUND: FIBRONET was an observational, multicentre, prospective cohort study investigating the baseline characteristics, clinical course of disease and use of antifibrotic treatment in Italian patients with idiopathic pulmonary fibrosis (IPF). METHODS: Patients aged ≥ 40 years diagnosed with IPF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poletti, V., Vancheri, C., Albera, C., Harari, S., Pesci, A., Metella, R. R., Campolo, B., Crespi, G., Rizzoli, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903602/ https://www.ncbi.nlm.nih.gov/pubmed/33627105 http://dx.doi.org/10.1186/s12931-021-01643-w

Ejemplares similares

Where do we stand with IPF treatment?
por: Albera, C, et al.
Publicado: (2013)

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study
por: Raman, Lavanya, et al.
Publicado: (2023)

Quantitative Evaluation of Fibrosis in IPF Patients: Meaning of Diffuse Pulmonary Ossification
por: Palermo, Monica, et al.
Publicado: (2021)

The pathogenesis of COPD and IPF: Distinct horns of the same devil?
por: Chilosi, Marco, et al.
Publicado: (2012)

Idiopathic Pulmonary Fibrosis in Elderly Patients: Analysis of the INSIGHTS-IPF Observational Study
por: Leuschner, Gabriela, et al.
Publicado: (2020)

The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
por: Guenther, Andreas, et al.
Publicado: (2018)

Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience
por: Levra, Stefano, et al.
Publicado: (2022)

Development of the ATAQ-IPF: a tool to assess quality of life in IPF
por: Swigris, Jeffrey J, et al.
Publicado: (2010)

Unsupervised machine learning identifies predictive progression markers of IPF
por: Pan, Jeanny, et al.
Publicado: (2022)

The COPD multi-dimensional phenotype: A new classification from the STORICO Italian observational study
por: Antonelli Incalzi, Raffaele, et al.
Publicado: (2019)

Raising awareness on physician-patient communication in IPF: an Italian multicenter study exploring the pulmonologist’s perspective
por: Tomassetti, Sara, et al.
Publicado: (2021)

Recommendations on treatment for IPF
por: Behr, Jürgen, et al.
Publicado: (2013)

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
por: Jo, Helen E., et al.
Publicado: (2019)

Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF
por: Tóth, Nóra Melinda, et al.
Publicado: (2023)

IPF clinical trial design and endpoints
por: Nathan, Steven D., et al.
Publicado: (2014)

Historical eye on IPF: a cohort study redefining the mortality scenario
por: Tomassetti, Sara, et al.
Publicado: (2023)

Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO)
por: Polverino, Francesca, et al.
Publicado: (2020)

Highlights of HRCT imaging in IPF
por: Sverzellati, N
Publicado: (2013)

IPF - Idiopathic Pulmonary Fibrosis
Publicado: (2019)

The role of neutrophils in the pathogenesis of IPF
por: Jegal, Yangjin
Publicado: (2022)

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2019)

Neurodevelopmental Outcomes in Preterm Babies: A 12-Month Observational Study
por: Jain, Shresth, et al.
Publicado: (2023)

Epigenetic regulation of IPF fibroblast phenotype by glutaminolysis
por: Xiang, Zheyi, et al.
Publicado: (2022)

An Italian Observer of the Edinburgh Surgical School
Publicado: (1891)

Rapidly non-ipf progressive fibrosing interstitial lung disease: a phenotype with an ipf-like behavior
por: Khine, Ngu, et al.
Publicado: (2020)

Prognosis of the infected diabetic foot ulcer: a 12‐month prospective observational study
por: Ndosi, M., et al.
Publicado: (2017)

Mitochondrial Quality Control in COPD and IPF
por: Hara, Hiromichi, et al.
Publicado: (2018)

Idiopathic Pulmonary Fibrosis (IPF): An Overview
por: Barratt, Shaney L., et al.
Publicado: (2018)

The Role of Immunity and Inflammation in IPF Pathogenesis
por: Butler, Marcus W., et al.
Publicado: (2018)

Senescent Cells in IPF: Locked in Repair?
por: Meiners, Silke, et al.
Publicado: (2020)

IPF in Saudi Arabia: Lessons for all
por: Nathan, Steven D.
Publicado: (2020)

Microbiota and IPF: hidden and detected relationships
por: Fabbrizzi, Alessio, et al.
Publicado: (2021)

Radiological and Physiological Predictors of IPF Mortality
por: Kishaba, Tomoo, et al.
Publicado: (2021)

Moving senolytics closer to the clinic in IPF
por: Kramer, Daniel, et al.
Publicado: (2023)

Primary mitochondrial myopathy: 12-month follow-up results of an Italian cohort
por: Montano, V., et al.
Publicado: (2022)

An Italian Observer of Our Edinburgh Medical School
Publicado: (1890)

12-month intravascular ultrasound observations from BiOSS® first-in-man studies
por: Gil, Robert J., et al.
Publicado: (2016)

Prelabour caesarean section and neurodevelopmental outcome at 4 and 12 months of age: an observational study
por: Zaigham, Mehreen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q3pss39tdaup9kvdb4gouci7t2